Richard Burr: “I deeply respect the work that they do.”

What does it mean for a small company when FDA misses these goals, and what does it mean to patients?

I question whether the agreements both passed and proposed reflect a good deal for patients they are designed to serve.

Ms. Kotagal's refusal to continue these common-sense measures speaks volumes of her lack of commitment to due process and transparency.

By statute, you are supposed to lead a pandemic. I am going to turn to you. Tell me what the plan is.